Sign in

    Seth Blackley

    Chief Executive Officer at Evolent Health Inc
    Since October 2020
    Age
    46 years
    Education
    Holds a Bachelor of Arts degree in business from The University of North Carolina at Chapel Hill and a Master of Business Administration from Harvard Business School.
    Tenure
    Joined as a co-founder of EVH, served as President from August 2011, and was promoted to Chief Executive Officer in October 2020.

    Also at Evolent Health Inc

    AS
    Aammaad Shams
    Chief Accounting Officer
    DM
    Dan McCarthy
    President
    ER
    Emily Rafferty
    Chief Operating Officer

    About

    Seth Blackley began his distinguished career in the healthcare and consulting sectors by working as an analyst at McKinsey & Company in Washington, D.C., and later held an executive role in corporate development and strategic planning at The Advisory Board from June 2007 to August 2011.

    He was instrumental in the founding of EVH, where he served as President starting in August 2011 before transitioning to the role of Chief Executive Officer in October 2020. His leadership marked a significant evolution in the company's strategic growth and operational success.

    Beyond his primary responsibilities at EVH, he further contributed to the healthcare industry by serving on the board of directors of Advanced Practice Strategies from 2014 to 2016, underscoring his commitment to enhancing healthcare practices and outcomes.

    $EVH Performance Under Seth Blackley

    Past Roles

    OrganizationRoleDate RangeDetails
    Evolent Health (EVH) President August 2011 - October 2020 Promoted to CEO in October 2020
    Evolent Health (EVH) Co-Founder N/A Co-founded the company
    The Advisory Board Executive Director of Corporate Development and Strategic Planning June 2007 - August 2011 N/A
    McKinsey & Company Analyst N/A Began his career in Washington, D.C. office

    External Roles

    OrganizationRoleDate RangeDetails
    Access Clinical Partners Board Member Current N/A
    Iodine Healthcare Board Member Current N/A

    Fixed Compensation

    Data from  FY 2023
    Component NameAmountPayment ScheduleAdditional Details
    Base Salary $783,333Prorated in 2023; adjustments made during the year with an increase effective March 1, 2023 (targeted at $800,000) Reflects the annual base salary for 2023, subject to prorations due to mid-year adjustments
    All Other Compensation $13,200Discretionary, paid as part of 401(k) matching contributions401(k) matching contributions provided up to 4% of the base salary, vesting over three years

    Performance Compensation

    Data from  FY 2023

    Annual Cash Incentive Plan (Bonus)

    MetricValueDetails
    Threshold (Meets Expectations)$400,000Corresponds to a performance rating of 3/5
    Target (Exceeds Expectations)$800,000Corresponds to a performance rating of 4/5
    Maximum (Exceptional Performance)$1,200,000Corresponds to a performance rating of 5/5; achieved as the actual payout based on performance evaluation
    • Evaluation Period & Vesting: This cash incentive is performance-based and evaluated by the Compensation Committee without an associated vesting schedule, as it is a cash bonus.
    • Additional Notes: There is no grant date, grant date fair value, or stock price since this incentive is not equity-based.